ROSEMONT, Ill.--(BUSINESS WIRE)--Proteintech, a global leader in antibodies and life science solutions, is excited to announce additional product characterization for primary antibody targets on its ...

ROSEMONT, Ill., September 02, 2025--(BUSINESS WIRE)--Proteintech, a global leader in antibodies and life science solutions, today announced the launch of Able AI, a first-of-its-kind artificial ...

New office and laboratory expansions enable Proteintech to accelerate growth in R&D, product development, production and customer support ROSEMONT, Ill.--(BUSINESS WIRE)--Proteintech, the benchmark in ...

insights from industryDr. Karolina SzczesnaProduct Manager and Technical SupportProteintech An interview with Dr. Karolina Szczesna from Proteintech at SfN 2018, discussing the tell-tale signs of a ...

In an industry first, Proteintech has unveiled Able AI, an artificial intelligence (AI) platform designed specifically to assist scientists in selecting research reagents and optimizing experimental ...

With this certification, Proteintech’s HumanKine® Human cell-expressed cytokines and growth factors are now available in GMP-compliant versions for use in clinical trials and commercial manufacturing.

ROSEMONT - Proteintech said it has tripled the size of its headquarters and laboratories to expand its antibody conjugation capabilities and add clinical capabilities to its antibodies' portfolio.

ChromoTek is the market leader in nanobodies — high-performance recombinant reagents used for breakthrough research discoveries. The combined companies will better address the industry’s growing ...

The 3D Epitope Mapping is a state-of-the-art solution that utilizes a combination of experimental techniques, including peptide scanning and microbial display, aiming to precisely map the antibody ...

Proteintech, announced the launch of Able AI, a first-of-its-kind artificial intelligence tool that is now available on (ptglab.com). This capability reduces guesswork and trial-and-error, enabling ...